Business
CSL rules out making homegrown mRNA COVID vaccine – Sydney Morning Herald
The local biotech giant’s boss, Paul Perreault, says mRNA technology will be used to develop a treatment against flu instead…
The Australian Shareholders Association also whether the board had considered intervening in Mr Perreaults 2021 pay, after he received $61 million in total remuneration last year despite total shareholder return being zero. Mr McNamee said this total came…
Continue Reading
-
Noosa News16 hours agoBike riders to cycle across the traffic lanes of the Story Bridge
-
Business19 hours agoThese are the 10 most shorted ASX shares 9 June 2025
-
Noosa News22 hours agoMen extradited from NSW to face deprivation of liberty and extortion charges
-
General15 hours agoHeroic surfing priest rescues father and son from rip at Cable Beach